SCHEMBL23746337

SCHEMBL23746337

COCC[C@H](O)c1cccc(C(=O)OC)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.48
CASR P41180 3/20 0.47
CYP4F2 P78329 2/20 0.47
CYP4A11 Q02928 2/20 0.47
RAB9A P51151 1/20 0.46
ADRB2 P07550 1/20 0.45
ADRB1 P08588 1/20 0.45
ADRB3 P13945 1/20 0.45
SLC7A5 Q01650 1/20 0.45
ALDH1A1 P00352 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPK1 P28482 1/20 0.44
TSHR P16473 1/20 0.43
FOLH1 Q04609 1/20 0.42
POLB P06746 1/20 0.42
F2 P00734 1/20 0.42
F10 P00742 1/20 0.42
PRSS1 P07477 1/20 0.42
GPR17 Q13304 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23732388 1.00 LOXL2 (0.48) LOXL2CASRCYP4F2CYP4A11RAB9A
SCHEMBL23746338 1.00 LOXL2 (0.48) LOXL2CASRCYP4F2CYP4A11RAB9A
SCHEMBL31226811 1.00 LOXL2 (0.48) LOXL2CASRCYP4F2CYP4A11RAB9A
SCHEMBL3182845 0.87 CYP4F2 (0.55) LOXL2CASRCYP4F2CYP4A11RAB9A
SCHEMBL31226962 0.85 LOXL2 (0.51) LOXL2CASRCYP4F2CYP4A11RAB9A
SCHEMBL27823837 0.85 LOXL2 (0.48) LOXL2CASRCYP4F2CYP4A11ADRB2
SCHEMBL9359858 0.83 CYP4F2 (0.54) LOXL2CASRCYP4F2CYP4A11RAB9A
SCHEMBL5662355 0.83 LOXL2 (0.51) LOXL2CASRCYP4F2CYP4A11RAB9A
SCHEMBL4794922 0.83 LTB4R (0.51) LOXL2CASRCYP4F2CYP4A11
SCHEMBL6330723 0.82 LOXL2 (0.58) LOXL2CASRCYP4F2CYP4A11RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12629374-B2 Antimalarial agents MERCK SHARP & DOHME LLC (US) 2026-05-19 US disclosed
US-20230139282-A1 ANTIMALARIAL AGENTS MERCK SHARP & DOHME LLC (US) 2023-05-04 US disclosed
US-20230139282-A1 ANTIMALARIAL AGENTS MERCK SHARP & DOHME LLC (US) 2023-05-04 US disclosed
US-20230139282-A1 ANTIMALARIAL AGENTS MERCK SHARP & DOHME LLC (US) 2023-05-04 US disclosed
WO-2021155791-A1 ANTIMALARIAL AGENTS MERCK SHARP & DOHME CORP. (US) 2021-08-12 WO disclosed
WO-2021155612-A1 ANTIMALARIAL AGENTS MERCK SHARP & DOHME CORP. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139282-A1 ANTIMALARIAL AGENTS G6PD, MTX1, OAT LOXL2 3649/4885CASR 4588/4885CYP4F2 279/4885
US-12629374-B2 Antimalarial agents CLIC1, CYC1, HCCS LOXL2 2918/4885CASR 3175/4885CYP4F2 623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.